Blood tests can detect a wide range of drugs, from alcohol and cannabis to opioids, cocaine, amphetamines, and benzodiazepines. The catch is that blood offers one of the shortest detection windows of any biological sample. For most substances, a single dose is detectable in blood for roughly one to two days, which makes blood testing especially useful when the question is whether someone is under the influence right now rather than whether they used something last week. That short window, along with the invasiveness of a blood draw, shapes when and why blood tests are used instead of the more common urine screen.
What a Blood Drug Test Actually Measures
When drugs enter your bloodstream, they circulate in their original form (the parent drug) and are gradually broken down by your liver and other organs into metabolites. A blood test can pick up both. A cocaine blood test, for example, looks for cocaine itself and for benzoylecgonine, its primary metabolite. In a study of drivers suspected of impairment, more than half of samples that were positive for cocaine-related substances contained both the parent drug and benzoylecgonine, with the metabolite typically present at higher concentrations.1PubMed Central. Cocaine and benzoylecgonine concentrations in fluorinated plasma samples of drivers under suspicion of driving under influence This matters because the ratio of parent drug to metabolite can help forensic analysts estimate how recently someone used a substance.
Most blood drug tests follow a two-stage process. The first stage is an immunoassay screen, a rapid test that flags whether a sample is likely positive for a drug class. These screens are fast but imperfect. The second stage is a confirmatory test using more precise technology, typically liquid or gas chromatography coupled with mass spectrometry. Confirmatory tests identify the exact compound and its concentration. An evaluation of several immunoassay platforms used on whole blood found that screening accuracy varied quite a bit depending on the drug class. Sensitivities ranged from around 67% for amphetamines on one platform up to 100% for cannabinoids and methadone on others, while specificities ranged from about 52% for methadone to 100% for benzodiazepines.2Oxford Academic (Journal of Analytical Toxicology). Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD In plain terms, a screening test that misses a third of amphetamine users is not a final verdict. The confirmatory step matters.
How Long Drugs Stay Detectable in Blood
Blood has the shortest practical detection window of the standard biological samples. For most drugs of abuse taken as a single dose, blood concentrations drop to undetectable levels within one to two days. Compare that to urine, where a single dose is typically detectable for one and a half to four days, and chronic users can test positive for roughly a week or, in extreme cases with cocaine and cannabis, even longer.3PubMed. Detection times of drugs of abuse in blood, urine, and oral fluid Hair testing can reach back months. Oral fluid sits between blood and urine, with a detection window of about 5 to 48 hours.3PubMed. Detection times of drugs of abuse in blood, urine, and oral fluid
These timelines are averages. The actual window for any specific person depends on the dose taken, how often they use, their metabolism, body composition, the specific drug’s half-life, and whether the drug accumulates in fat tissue. Cannabis is the most dramatic example of individual variation. THC is fat-soluble, so heavy, long-term users can have detectable blood levels for days after their last use, while an occasional user might clear the same dose from blood in under 24 hours.
Here is a rough guide to single-dose detection in blood for common substances:
- Cannabis (THC): Generally detectable for 12 to 24 hours in occasional users, but potentially several days in heavy users.
- Cocaine: Parent drug detectable for about 12 hours; benzoylecgonine may linger up to 48 hours.
- Amphetamines: Typically 24 to 48 hours depending on the specific compound.
- Opioids: Most are detectable for 12 to 36 hours, though longer-acting formulations stretch this.
- Benzodiazepines: Varies widely by compound, from hours for short-acting drugs to several days for long-acting ones like diazepam.
- Alcohol: Ethanol itself clears blood within hours, but specialized biomarkers can extend this window significantly.
Benzodiazepines Are Tricky to Screen For
Benzodiazepines deserve their own mention because the drug class is unusually diverse, and not all members show up equally on immunoassay screens. A study testing 38 different benzodiazepines and their metabolites found that while drugs like alprazolam, diazepam, and oxazepam were reliably detected by all four immunoassay platforms tested, others were completely invisible. Compounds like 7-amino-clonazepam, haloxazepam, and loprazolam were not detected by any of the assays at concentrations up to 70 nanograms per milliliter.4PubMed. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood Several others fell in a gray area, detected by some platforms but not all.
This means a negative immunoassay screen for benzodiazepines in blood does not guarantee the person has not taken one. If a specific benzodiazepine is suspected, confirmatory testing with mass spectrometry is essential. This is relevant in forensic investigations and in medical settings where a patient arrives with unexplained sedation. The takeaway is that immunoassay screens are class-level tools, and within the benzodiazepine class, coverage is uneven.
Blood Tests for Alcohol Go Beyond a Simple BAC
Ethanol itself is detectable in blood for only a few hours after drinking stops, which is why a standard blood alcohol concentration test is useful for proving current intoxication but not much else. For situations where the question is whether someone has been drinking heavily over days or weeks, specialized biomarkers exist. Two of the most studied are ethyl glucuronide (EtG) and phosphatidylethanol (PEth).
EtG is a direct metabolite of ethanol that can be measured in blood and reflects drinking within the past day or two. PEth is a phospholipid that forms in cell membranes only when ethanol is present and accumulates with repeated drinking, making it a marker of longer-term consumption stretching back weeks. A study analyzing over 1,100 blood samples found that while 95 samples were positive for ethanol itself, 454 were positive for EtG and 635 were positive for PEth. The two biomarkers turned out to be largely independent of each other, reflecting different time windows of alcohol exposure.5PubMed Central. Phosphatidylethanol, ethyl glucuronide and ethanol in blood as complementary biomarkers for alcohol consumption Clinicians and forensic experts now often use EtG and PEth together to build a more complete picture of a person’s recent drinking pattern, rather than relying solely on whether ethanol happens to be in the blood at the moment of testing.
When Blood Testing Is Preferred Over Urine
Given that urine testing is cheaper, less invasive, and has a longer detection window, you might wonder why blood tests exist at all for drug screening. The answer comes down to timing and precision. Blood concentrations correlate more closely with how impaired someone is right now. A positive urine test tells you a drug was in someone’s system recently but says little about whether it is currently affecting them. A positive blood test, especially one with quantified concentrations, is much more informative about current impairment.
This is why blood testing is standard in driving-under-the-influence investigations, emergency department evaluations, and workplace accident investigations where the question is “were they under the influence at the time?” rather than “have they used drugs recently?” It is also why forensic toxicology relies heavily on blood. If a pilot crashes, investigators want to know whether drugs were active in the bloodstream at the time, not whether the pilot smoked cannabis two weeks earlier.
The flip side is that the short detection window works against blood testing in other contexts. Pre-employment drug screening, probation monitoring, and addiction treatment programs almost always use urine, hair, or oral fluid because they need to catch use that happened days or weeks ago. Blood testing would miss too much.
Cannabis, Blood Levels, and the Legal Mess
Cannabis occupies an especially contentious space in blood drug testing. Several U.S. states have established per se legal limits for THC in blood, meaning it is a criminal violation to drive with THC concentrations above a set threshold regardless of whether the driver appears impaired. Colorado and Washington, for example, set the limit at 5 nanograms per milliliter. But the relationship between blood THC concentration and actual impairment is far less straightforward than it is for alcohol.
Critics of per se cannabis limits point out that neither the presence of THC nor its metabolites are consistent predictors of psychomotor impairment, and that these laws can result in convictions of people who consumed cannabis at some earlier point but are no longer impaired.6Humboldt Journal of Social Relations. Should Per Se Limits Be Imposed For Cannabis? Equating Cannabinoid Blood Concentrations with Actual Driver Impairment: Practical Limitations and Concerns Heavy daily users, for instance, can have residual THC in blood well above 5 ng/mL even when they are not acutely intoxicated, simply because THC accumulates in body fat and slowly leaks back into the bloodstream.
Timing compounds the problem. A study of DUI traffic arrests found that between 42% and 70% of all cannabinoid-positive drivers tested below the 5 ng/mL legal limit in blood. Given typical delays between a traffic stop and a blood draw, THC concentrations can drop substantially by the time the sample is collected, even for drivers who were genuinely impaired at the time of the arrest.7PubMed. Delays in DUI blood testing: Impact on cannabis DUI assessments So blood testing both over-captures some sober chronic users and under-captures some recently impaired drivers. The science is far messier than the legal framework suggests.
False Positives and Cross-Reactivity
Immunoassay drug screens, whether run on blood or urine, are designed to detect drug classes rather than individual compounds. This design means certain legal medications and even over-the-counter products can trigger a false positive. A review identified 25 reports of false-positive results on urine drug screens linked to common medications including diphenhydramine, ibuprofen, naproxen, sertraline, bupropion, quetiapine, dextromethorphan, and venlafaxine, among others.8PubMed. Commonly prescribed medications and potential false-positive urine drug screens While this review focused on urine, many of the same immunoassay principles apply to blood screens, and cross-reactivity issues carry over.
The practical lesson is that an initial positive screen is never the final word. If you are taking any prescription or over-the-counter medication and face a drug test, mention it beforehand. More critically, any decision with legal or employment consequences should rest on confirmatory testing, not on the immunoassay screen alone. The screening step exists to narrow down which samples need the expensive, time-consuming confirmatory analysis. Treating a screen result as proof is a misuse of the technology.
Novel Psychoactive Substances Are Hard to Catch
Standard blood drug panels are built around well-known substance classes. If someone has used a newer synthetic compound, whether a synthetic cathinone, a novel benzodiazepine analog, or a designer cannabinoid, the standard immunoassay screen will often miss it entirely. These novel psychoactive substances (NPS) change constantly as manufacturers tweak molecular structures to stay ahead of regulation, and immunoassays cannot detect what they were not designed to find.
Identifying NPS requires advanced analytical methods like liquid or gas chromatography coupled with mass spectrometry. These techniques are powerful but come with drawbacks: the equipment is expensive, results take hours rather than minutes, specialized technicians are needed, and reference standards for the newest compounds may not even exist yet.9PubMed Central. Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication In an emergency department, this means a patient showing clear signs of intoxication may have a completely clean standard drug screen, and hours may pass before the actual substance is identified. For clinicians treating acute intoxication, this gap is a real problem because treatment decisions often need to be made before analytical results come back.
How Blood Samples Are Stored and Why It Matters
Once blood is drawn, the sample’s integrity depends on how it is handled and stored. Drug concentrations in blood are not frozen in time the moment the needle goes in. Certain compounds degrade, others redistribute within the sample, and contamination or improper preservation can alter results.
Temperature is the biggest factor. A study on synthetic cathinones in whole blood found that storage at minus 40°C provided the best stability for all tested compounds, while room temperature storage led to significant degradation. Adding sodium fluoride, a common preservative, did not meaningfully improve stability except at room temperature.10PubMed Central. Influence of long-term storage temperatures and sodium fluoride preservation on the stability of synthetic cathinones and dihydro-metabolites in human whole blood For more stable compounds like phencyclidine (PCP), concentrations held reasonably steady for a year in cold storage but showed a roughly 10% decrease after two years and about 18% after three.11PubMed. Stability of phencyclidine in stored blood samples
These stability concerns are not academic. In legal cases, blood evidence may sit in storage for months or years before trial. If a defendant’s sample was stored improperly or analyzed long after collection, the measured concentration could be meaningfully lower than the actual concentration at the time of the blood draw. Defense attorneys in DUI and drug cases sometimes challenge results on exactly these grounds.
Drug Levels After Death Are Not What They Seem
In death investigations, toxicology results from blood draw during autopsy require careful interpretation because of a phenomenon called postmortem redistribution. After someone dies, drugs that had been concentrated in organs like the liver, lungs, and heart muscle can leak back into the surrounding blood. This means a blood sample taken from near the heart during an autopsy may show drug concentrations that are significantly higher than what the person actually had in their bloodstream while alive.12PubMed. Key concepts in postmortem drug redistribution
The degree of redistribution depends on the specific drug, the site from which blood is collected, the time between death and sampling, and environmental conditions. Drugs that are highly lipophilic or have large volumes of distribution tend to redistribute more dramatically. This is why forensic toxicologists strongly prefer blood drawn from the femoral vein in the leg, which is far from major organs and less affected by redistribution, over blood taken from the chest cavity.13PubMed Central. Postmortem redistribution of drugs: a literature review Misinterpreting postmortem drug levels has real consequences. An artificially elevated drug concentration could lead to a wrongful determination that an overdose was the cause of death, or it could obscure the role of another cause. Forensic pathologists treat postmortem blood drug levels as estimates requiring context, not as precise measurements of what was happening at the moment of death.
How Roadside and Workplace Testing Fits In
In practice, blood testing is rarely the first step in drug screening. Roadside checks for impaired driving typically begin with oral fluid testing or field sobriety assessments, with blood draws ordered afterward if there is probable cause. A Norwegian study estimating the prevalence of driving with drug concentrations above proposed legal limits found that about 1.5% of drivers had blood levels exceeding those thresholds, which represented roughly 40% of drivers who had tested positive in oral fluid.14PubMed. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid The gap illustrates that a positive oral fluid test does not automatically mean blood levels are high enough to cross a legal threshold. Many people with trace amounts of a drug in their saliva have already metabolized most of it from their blood.
Workplace drug testing almost never starts with blood. The standard approach uses urine immunoassay screening, sometimes with oral fluid as an alternative. Blood draws are typically reserved for post-accident investigations or for confirming contested results. If you are facing a routine pre-employment or random workplace drug test, it will almost certainly be urine or oral fluid, not blood. Blood testing enters the picture when the stakes are higher and the question is more specific.